BI signs schizophrenia app deal with Click Therapeutics

Boehringer Ingelheim has signed a $500 million contract with Click Therapeutics to co-develop and market a digital treatment for patients with schizophrenia.

Digital therapy firms link up with Swiss accelerator Kicksta...

Several digital therapy and digital health firms have been selected to join a group of startups by the innovation platform, Kickstart, linking them with a range of investors in an initiativ

FDA approves Akili's video game ADHD therapy

The FDA has approved the first video game-based treatment for attention deficit hyperactivity disorder (ADHD), from Akili. 

COVID-19 gives Akili’s digital ADHD treatment an early debut...

Personalising digital mental health treatment

In the age of smartphones and virtual reality, NHS trusts must evolve their approach to reach patients, and can look towards a future of clinically proven personalised digital therapeutic t

Digital therapeutics formularies five years away in US, say ...

Payers from the US may not include digital therapeutics products on formularies for another five years, according to a report.